
22.41 Delayed Data As of Sep 29 | ![]() Today’s Change | 22.03 Today|||52-Week Range 59.84 | -41.29% Year-to-Date |
PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024 Sep 29 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains? Sep 20 / Zacks.com - Paid Partner Content |
Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down Sep 21 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD Drug Sep 18 / Zacks.com - Paid Partner Content |
Previous close | 22.66 |
Today’s open | 22.94 |
Day’s range | 22.24 - 23.35 |
Volume | 35,219 |
Average volume (3 months) | 928,134 |
Market cap | $1.7B |
Earnings growth (last year) | -4.82% |
Earnings growth (this year) | +46.38% |
Earnings growth (next 5 years) | +2.00% |
Revenue growth (last year) | +29.75% |
P/E ratio | NM |
Price/Sales | 3.92 |
Price/Book | -- |
Next reporting date | October 26, 2023 |
EPS forecast (this quarter) | -$1.08 |
Annual revenue (last year) | $698.8M |
Annual profit (last year) | -$559.0M |
Net profit margin | -80.00% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South Plainfield, New Jersey |